Join host Joe Selvaggi and Pioneer’s Bill Smith in a conversation with Hannah Mamuszka, expert in diagnostic medicine, on why the U.S. lacked adequate early testing, what current testing looks like in the Commonwealth, and where testing technology needs to be to support public gatherings in the future.
Interview Guest:
Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.
Oops! We could not locate your form.
Related Posts
How Public Transportation’s Efficiency Changed During Covid
As COVID-19 Emergencies Ease, Some Progress on Telehealth Rules
Khan Academy’s Sal Khan & ASU Prep Digital’s Amy McGrath on the Khan World School @ ASU Prep
Pandemic Dead Reckoning: Unseen Casualties of Public Health Interventions
Why the jump in non-COVID deaths?
Mandate’s Constitutional Collision: Court Offers Civics Lesson with Vaccine Rulings
How did COVID impact Massachusetts’ long-term care facilities?